摘要
目的:探讨纤维支气管镜检查结合血清标志物检查对中央型肺癌的诊断价值分析。方法:回顾性选取2018年12月~2019年12月于本院呼吸内科收治并确诊为中央型肺癌的患者141例作为研究对象,分为三组,行纤维支气管镜检查、血清标志物检查及纤维支气管镜检查结合血清标志物检查,分析各种检查的诊断价值,将诊断结果作为金标准。结果:所有患者经纤维支气管镜和血清标志物检查,确诊率为100%,其中纤维支气管镜检查结合血清标志物检查诊断检出率93.62%明显高于纤维支气管镜检查76.60%和血清标志物检查72.34%,差异具有统计学意义(P<0.05)。结论:在中央型肺癌的实验室诊断中,纤维支气管镜检查与血清标志物检查联合应用疾病检出率较高,对不同病理类型疾病诊断价值高,为治疗方案的制定提供参考指标。
Objective:To explore The value of fiberoptic bronchoscopy combined with serum markers in the diagnosis of central lung cancer.Methods:From December 2018 to December 2019,141 patients with central lung cancer admitted to the respiratory department of our hospital were selected as the study object.The patients divided into three groups,the first group underwent fiberoptic bronchoscopy,the second group patients underwent serum markers examination,the third group underwent fiberoptic bronchoscopy combined with serum markers.Diagnostic value of various examinations were analyzed.The diagnosis result were used as the gold standard.Results:The diagnosis rate of the patients examined by fiberoptic bronchoscopy and serum markers was 100%.The detection rate of fiberoptic bronchoscopy combined with serum markers was 93.62%,which was significantly higher than fiberoptic bronchoscopy of 76.60%and serum markers examination of 72.34%,the difference was statistically significant(P<0.05).Conclusion:In the laboratory diagnosis of central lung cancer,the combined application of fiberoptic bronchoscopy and serum markers has a high detection rate,high diagnostic value for different pathological types of diseases,and provides reference indicators for the formulation of treatment plans.
作者
佟丽莉
TONG Li-li(Department of Respiration,Air Force Hospital of the Northern Theater of the Chinese People’s Liberation Army,Liaoning Shenyang 110042)
出处
《中国医疗器械信息》
2021年第6期131-132,共2页
China Medical Device Information
关键词
纤维支气管镜检查
血清标志物检查
中央型肺癌
临床诊断
fiberoptic bronchoscopy
serum markers examination
central lung cancer
clinical diagnosis